Hazebroek M R, Kemna M J, Schalla S, Sanders-van Wijk S, Gerretsen S C, Dennert R, Merken J, Kuznetsova T, Staessen J A, Brunner-La Rocca H P, van Paassen P, Cohen Tervaert J W, Heymans S
Maastricht University Medical Centre, Department of Cardiology, Maastricht, The Netherlands.
CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands; Maastricht University Medical Centre, Department of Nephrology and Clinical Immunology, Internal Medicine, Maastricht, The Netherlands.
Int J Cardiol. 2015 Nov 15;199:170-9. doi: 10.1016/j.ijcard.2015.06.087. Epub 2015 Jul 15.
To investigate the prevalence and prognostic relevance of cardiac involvement in an ANCA-associated vasculitis (AAV) population of eosinophilic granulomatosis with polyangiitis (EGPA) and granulomatosis with polyangiitis (GPA) patients.
Prospective cohort study of fifty EGPA and forty-one GPA patients in sustained remission without previous in-depth cardiac screening attending our clinical immunology outpatient department. Cardiac screening included clinical evaluation, ECG, 24-hour Holter registration, echocardiography and cardiac magnetic resonance imaging (CMR) with coronary angiography and endomyocardial biopsy upon indication. Fifty age-, sex- and cardiovascular risk factor-matched control subjects were randomly selected from a population study. Long-term outcome was assessed using all-cause and cardiovascular mortality.
A total of 91 AAV-patients (age 60±11, range 63-87years) were compared to 50-matched control subjects (age 60±9years, range 46-78years). ECG and echocardiography demonstrated cardiac abnormalities in 62% EGPA and 46% GPA patients vs 20% controls (P<0.001 and P=0.014, respectively). A total of 69 AAV-patients underwent additional CMR, slightly increasing the prevalence of cardiac involvement to 66% in EGPA and 61% in GPA patients. After a mean follow-up of 53±18months, presence of cardiac involvement using ECG and echocardiography in AAV-patients showed increased all-cause and cardiovascular mortality (Log-rank P=0.015 and Log-rank P=0.021, respectively).
Cardiac involvement in EGPA and GPA patients with sustained remission is high, even if symptoms are absent and ECG is normal. Moreover, cardiac involvement is a strong predictor of (cardiovascular) mortality. Therefore, risk stratification using cardiac imaging is recommended in all AAV-patients, irrespective of symptoms or ECG abnormalities.
调查嗜酸性肉芽肿性多血管炎(EGPA)和肉芽肿性多血管炎(GPA)患者组成的抗中性粒细胞胞浆抗体相关性血管炎(AAV)人群中心脏受累的患病率及其预后相关性。
对50例EGPA患者和41例GPA患者进行前瞻性队列研究,这些患者处于持续缓解状态,此前未接受过深入的心脏筛查,在我们临床免疫科门诊就诊。心脏筛查包括临床评估、心电图、24小时动态心电图记录、超声心动图以及必要时进行的冠状动脉造影和心内膜心肌活检的心脏磁共振成像(CMR)。从一项人群研究中随机选取50名年龄、性别和心血管危险因素匹配的对照受试者。使用全因死亡率和心血管死亡率评估长期结局。
共将91例AAV患者(年龄60±11岁,范围63 - 87岁)与50名匹配的对照受试者(年龄60±9岁,范围46 - 78岁)进行比较。心电图和超声心动图显示,62%的EGPA患者和46%的GPA患者存在心脏异常,而对照受试者中这一比例为20%(分别为P<0.001和P = 0.014)。共有69例AAV患者接受了额外的CMR检查,这使得EGPA患者和GPA患者心脏受累的患病率略有增加,分别为66%和61%。平均随访53±18个月后,AAV患者中通过心电图和超声心动图显示存在心脏受累的患者全因死亡率和心血管死亡率均升高(对数秩检验P分别为0.015和0.021)。
EGPA和GPA持续缓解患者的心脏受累情况很常见,即使没有症状且心电图正常。此外,心脏受累是(心血管)死亡率的有力预测指标。因此,建议对所有AAV患者进行心脏成像风险分层,无论其有无症状或心电图异常。